BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38255317)

  • 1. Comparison between Peritumoral and Intratumoral Budding in Colorectal Cancer.
    Pyo JS; Choi JE; Kim NY; Min KW; Kang DW
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological Significances of Peritumoral Budding in Colorectal Cancer: A Detailed Analysis Based on Mucinous and Micropapillary Pattern.
    Pyo JS; Kim NY; Min KW; Kang DW
    Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological Significances and Prognostic Role of Intratumoral Budding in Colorectal Cancers.
    Kang G; Pyo JS; Kim NY; Kang DW
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas.
    Thies S; Guldener L; Slotta-Huspenina J; Zlobec I; Koelzer VH; Lugli A; Kröll D; Seiler CA; Feith M; Langer R
    Hum Pathol; 2016 Jun; 52():1-8. PubMed ID: 26980046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Implications of Intratumoral Budding in Colorectal Cancer: Detailed Analysis Based on Tumor-Infiltrating Lymphocytes.
    Pyo JS; Choi JE; Kim NY; Min KW; Kang DW
    J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral budding: A novel prognostic biomarker for tumor recurrence and a potential predictor of nodal metastasis in uterine cervical cancer.
    Chong GO; Jee-Young Park N; Han HS; Cho J; Kim MG; Choi Y; Yeo JY; Lee YH; Hong DG; Park JY
    Eur J Surg Oncol; 2021 Dec; 47(12):3182-3187. PubMed ID: 34284905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of tumor budding, desmoplastic reaction, and lymphocytic infiltration in patients with gastric adenocarcinoma.
    Yavuz A; Simsek K; Alpsoy A; Altunay B; Gedik EO; Unal B; Bassorgun CI; Tatli AM; Elpek GO
    World J Gastrointest Pathophysiol; 2024 Apr; 15(1):91237. PubMed ID: 38682027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of peritumoural and intratumoural budding in intestinal-type gastric adenocarcinoma.
    Qi B; Liu L; Pan Y; Xu S; Li J
    Arab J Gastroenterol; 2020 Jun; 21(2):111-116. PubMed ID: 32423856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
    Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
    Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour budding as a prognostic biomarker in biopsies and resections of neoadjuvant-treated rectal adenocarcinoma.
    Aherne S; Donnelly M; Ryan ÉJ; Davey MG; Creavin B; McGrath E; McCarthy A; Geraghty R; Gibbons D; Nagtegaal I; Lugli A; Kirsch R; Martin ST; Winter DC; Sheahan K;
    Histopathology; 2024 Apr; ():. PubMed ID: 38629323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Budding and Poorly Differentiated Clusters in Small Intestinal Adenocarcinoma.
    Jun SY; Chung JY; Yoon N; Jung ES; Oh YH; Hong SM
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32781596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of Intratumoral and Peritumoral Budding in Distal Extrahepatic Bile Duct Carcinoma.
    Jun SY; Hong SM; An S
    Pathobiology; 2023 Dec; ():. PubMed ID: 38113866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Retrospective Study of Association of Tumor Budding, Tumor Microenvironment, and Clinicopathological Characteristics of Invasive Breast Carcinoma.
    Singh T; Chandra K; Kumar N; Mishra A; Singh S; Singh A; Kumar U; Kumar P
    J Lab Physicians; 2022 Dec; 14(4):485-490. PubMed ID: 36531557
    [No Abstract]   [Full Text] [Related]  

  • 14. Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer.
    Rieger G; Koelzer VH; Dawson HE; Berger MD; Hädrich M; Inderbitzin D; Lugli A; Zlobec I
    Histopathology; 2017 Jun; 70(7):1044-1051. PubMed ID: 28061021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell Line Derived Xenograft Mouse Models Are a Suitable
    Georges LMC; De Wever O; Galván JA; Dawson H; Lugli A; Demetter P; Zlobec I
    Front Med (Lausanne); 2019; 6():139. PubMed ID: 31316988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential prognostic role of peritumoral eosinophils within whole tumor-associated inflammatory cells and stromal histological characteristics in colorectal cancer.
    Ramadan S; Saka B; Yarikkaya E; Bilici A; Oncel M
    Pol J Pathol; 2020; 71(3):207-220. PubMed ID: 33112111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma.
    Wartenberg M; Zlobec I; Perren A; Koelzer VH; Gloor B; Lugli A; Karamitopoulou E
    Oncotarget; 2015 Feb; 6(6):4190-201. PubMed ID: 25669968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor budding to investigate local invasion, metastasis and prognosis in temporal bone squamous cell carcinoma.
    Alessandrini L; Zanoletti E; Cazzador D; Sbaraglia M; Franz L; Tealdo G; Frigo AC; Blandamura S; Nicolai P; Mazzoni A; Marioni G
    Pathol Res Pract; 2022 Jan; 229():153719. PubMed ID: 34953406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining.
    Blank A; Schenker C; Dawson H; Beldi G; Zlobec I; Lugli A
    Front Med (Lausanne); 2019; 6():247. PubMed ID: 31737639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
    Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
    Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.